Halozyme Therapeutics
HALO
#2478
Rank
NZ$9.89 B
Marketcap
$77.78
Share price
-15.40%
Change (1 day)
17.41%
Change (1 year)

Halozyme Therapeutics (HALO) Fails to deliver data

Key failure to deliver metrics for Halozyme Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Halozyme Therapeutics (HALO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Halozyme Therapeutics (HALO) - since 2013

Volume in USD (price x number of shares), data since 2013

Halozyme Therapeutics (HALO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$17.9 M-29.77%
2023NZ$25.5 M-15.59%
2022NZ$30.2 M38.39%
2021NZ$21.82 M-6.23%
2020NZ$23.27 M-44.23%
2019NZ$41.74 M591.9%
2018NZ$6.03 M-64.48%
2017NZ$16.98 M-5.65%
2016NZ$17.99 M-13.05%
2015NZ$20.7 M-7.81%
2014NZ$22.45 M140.61%
2013NZ$9.33 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
NZ$0.65 MNZ$13.58 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$41.73 MNZ$0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.62 MNZ$53.13 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$50.21 MNZ$0.38 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.64 MNZ$71.88 M๐Ÿ‡ซ๐Ÿ‡ท France
NZ$70.18 MNZ$0.32 B๐Ÿ‡บ๐Ÿ‡ธ USA